BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23939886)

  • 1. Multilocus sequence typing reveals genetic diversity of carbapenem- or ceftazidime-nonsusceptible Pseudomonas aeruginosa in China.
    Ji J; Wang J; Zhou Z; Wang H; Jiang Y; Yu Y
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5697-700. PubMed ID: 23939886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals.
    García-Castillo M; Del Campo R; Morosini MI; Riera E; Cabot G; Willems R; van Mansfeld R; Oliver A; Cantón R
    J Clin Microbiol; 2011 Aug; 49(8):2905-10. PubMed ID: 21697331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
    Cho HH; Kwon GC; Kim S; Koo SH
    J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbapenem-Nonsusceptible
    Asempa TE; Nicolau DP; Kuti JL
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31118271
    [No Abstract]   [Full Text] [Related]  

  • 5. Efflux system overexpression and decreased OprD contribute to the carbapenem resistance among extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa isolates from a Chinese university hospital.
    Liu Y; Li XY; Wan LG; Jiang WY; Li FQ; Yang JH
    Microb Drug Resist; 2013 Dec; 19(6):463-8. PubMed ID: 23865862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa clinical strains isolated from western Algeria between 2009 and 2012.
    Sefraoui I; Berrazeg M; Drissi M; Rolain JM
    Microb Drug Resist; 2014 Apr; 20(2):156-61. PubMed ID: 24320688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of MDR and XDR Pseudomonas aeruginosa isolates obtained from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial.
    Pérez A; Gato E; Pérez-Llarena J; Fernández-Cuenca F; Gude MJ; Oviaño M; Pachón ME; Garnacho J; González V; Pascual Á; Cisneros JM; Bou G
    J Antimicrob Chemother; 2019 May; 74(5):1244-1252. PubMed ID: 30753505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of carbapenem nonsusceptible Pseudomonas aeruginosa in Denmark: a nationwide, prospective study.
    Hansen F; Johansen HK; Østergaard C; Arpi M; Hansen DS; Littauer P; Holm A; Heltberg O; Schumacher H; Fuursted K; Lykke MA; Tønning B; Hammerum AM; Justesen US
    Microb Drug Resist; 2014 Feb; 20(1):22-9. PubMed ID: 23964748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.
    Del Barrio-Tofiño E; López-Causapé C; Cabot G; Rivera A; Benito N; Segura C; Montero MM; Sorlí L; Tubau F; Gómez-Zorrilla S; Tormo N; Durá-Navarro R; Viedma E; Resino-Foz E; Fernández-Martínez M; González-Rico C; Alejo-Cancho I; Martínez JA; Labayru-Echverria C; Dueñas C; Ayestarán I; Zamorano L; Martinez-Martinez L; Horcajada JP; Oliver A
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidation of Mechanisms of Ceftazidime Resistance among Clinical Isolates of Pseudomonas aeruginosa by Using Genomic Data.
    Kos VN; McLaughlin RE; Gardner HA
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3856-61. PubMed ID: 27067331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of carbapenem resistance mechanisms and integrons in Pseudomonas aeruginosa strains from blood samples in a French hospital.
    Rojo-Bezares B; Cavalié L; Dubois D; Oswald E; Torres C; Sáenz Y
    J Med Microbiol; 2016 Apr; 65(4):311-319. PubMed ID: 26838942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial Effects of β-Lactams on Imipenem-Resistant Ceftazidime-Susceptible Pseudomonas aeruginosa.
    Wi YM; Choi JY; Lee JY; Kang CI; Chung DR; Peck KR; Song JH; Ko KS
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter Evaluation of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Inhibitory Activity against Meropenem-Nonsusceptible Pseudomonas aeruginosa from Blood, Respiratory Tract, and Wounds.
    Grupper M; Sutherland C; Nicolau DP
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of multidrug-resistant (MDR) Pseudomonas aeruginosa isolated in a burn center.
    de Almeida Silva KCF; Calomino MA; Deutsch G; de Castilho SR; de Paula GR; Esper LMR; Teixeira LA
    Burns; 2017 Feb; 43(1):137-143. PubMed ID: 27595453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of SPM-1-producing Pseudomonas aeruginosa by rep-PCR in hospitals in Parana, Brazil.
    Kalluf KO; Arend LN; Wuicik TE; Pilonetto M; Tuon FF
    Infect Genet Evol; 2017 Apr; 49():130-133. PubMed ID: 27923770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unexpected mechanisms of resistance in Dutch Pseudomonas aeruginosa isolates collected during 14 years of surveillance.
    Croughs PD; Klaassen CHW; van Rosmalen J; Maghdid DM; Boers SA; Hays JP; Goessens WHF;
    Int J Antimicrob Agents; 2018 Sep; 52(3):407-410. PubMed ID: 29772393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of carbapenem-resistant Pseudomonas aeruginosa in selected hospitals of the Gulf Cooperation Council States: dominance of high-risk clones in the region.
    Zowawi HM; Syrmis MW; Kidd TJ; Balkhy HH; Walsh TR; Al Johani SM; Al Jindan RY; Alfaresi M; Ibrahim E; Al-Jardani A; Al Salman J; Dashti AA; Sidjabat HE; Baz O; Trembizki E; Whiley DM; Paterson DL
    J Med Microbiol; 2018 Jun; 67(6):846-853. PubMed ID: 29664716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outbreak of PER-1 and diversity of β-lactamases among ceftazidime-resistant Pseudomonas aeruginosa clinical isolates.
    Qing Y; Cao KY; Fang ZL; Huang YM; Zhang XF; Tian GB; Huang X
    J Med Microbiol; 2014 Mar; 63(Pt 3):386-392. PubMed ID: 24398232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse Genetic Background of Multidrug-Resistant Pseudomonas aeruginosa from Mainland China, and Emergence of an Extensively Drug-Resistant ST292 Clone in Kunming.
    Fan X; Wu Y; Xiao M; Xu ZP; Kudinha T; Bazaj A; Kong F; Xu YC
    Sci Rep; 2016 May; 6():26522. PubMed ID: 27198004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population structure of clinical Pseudomonas aeruginosa from West and Central African countries.
    Cholley P; Ka R; Guyeux C; Thouverez M; Guessennd N; Ghebremedhin B; Frank T; Bertrand X; Hocquet D
    PLoS One; 2014; 9(9):e107008. PubMed ID: 25187957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.